The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I, first-in-human, dose escalation study of intravenous TK216 in patients with relapsed or refractory Ewing sarcoma.
 
Noah Federman
No Relationships to Disclose
 
Paul A. Meyers
Stock and Other Ownership Interests - Amgen; Bayer; EI Dupont; Henry Schein; Jazz Pharmaceuticals; Mednax; Novartis; Procter & Gamble; Sigma-Aldrich
Honoraria - France Foundation (I)
Consulting or Advisory Role - Boehringer Ingelheim (I)
Speakers' Bureau - France Foundation (I)
Travel, Accommodations, Expenses - InterMune (I); Takeda
 
Najat C. Daw
Consulting or Advisory Role - Bayer; Incyte
 
Jeffrey Toretsky
No Relationships to Disclose
 
James Bradley Breitmeyer
Employment - Oncternal Therapeutics, Inc
Leadership - Oncternal Therapeutics
Stock and Other Ownership Interests - Oncternal Therapeutics
 
Arun S. Singh
No Relationships to Disclose
 
Langdon L. Miller
Employment - Oncternal Therapeutics
Leadership - Oncternal Therapeutics
Stock and Other Ownership Interests - Oncternal Therapeutics
 
Tilman Oltersdorf
Employment - Oncternal Therapeutics
Leadership - Oncternal Therapeutics
Stock and Other Ownership Interests - Oncternal Therapeutics
 
Deborah Jezior
Employment - Oncternal Therapeutics
 
Katayoun A. Jessen
Employment - Oncternal Therapeutics
 
Brian Lannutti
Employment - Oncternal Therapeutics
 
Joseph A. Ludwig
No Relationships to Disclose